...Jakob Maarbjerg Toft-Hansen; Line Brok Nørreslet; Ida Vittrup; Jacob Pontoppidan Thyssen; Tove Agner; Yasemin Topal Yüksel Introduction: Topical corticosteroid (TCS) phobia may negatively impact treatment adherence. Currently, there are few studies exploring trust and knowledge of TCS use among...

...%) and BA in 6 patients (16.2%). No cases of NA were included. 22 patients (59.4%) had skin phototype II or III. Regarding treatment, a combination of UVA1 phototherapy with high-potency topical corticosteroids seemed to show the highest efficacy with complete clearance of symptoms in 4 patients (10.8...

... combined with topical corticosteroids. However, current evidence supporting the utility of moisturizers for eczema remains low to moderate [1, 3]. Importantly, Van Zuuren et al. [1] were unable to conclude which moisturizers were most appropriate for specific areas of the body, duration of disease...

...Simon M. Müller; Dominique Tomaschett; Sebastian Euler; Deborah R. Vogt; Lisa Herzog; Peter Itin Background/Aims: Topical corticosteroid concerns (TCC) are an important issue in patients with atopic dermatitis, leading to non-adherence with poor disease control and increased health care costs...

...Barbara C. Böckle; David Jara; Werner Nindl; Werner Aberer; Norbert T. Sepp The treatment of chronic inflammatory skin disease is associated with the use of topical corticosteroids. Their efficacy, tolerability and adverse effects depend on several factors, specifically potency, type of preparation...

... effects, including cutaneous and systemic reactions (e.g., mercury, hydroquinone and topical corticosteroids). Objectives: To assess the knowledge, attitudes and practices of women regarding skin-lightening products and to quantify the potentially harmful substances in the products used. Methods: We...

... subclinical inflammation. Objective: To evaluate clinical and cytological effects of pimecrolimus in topical corticosteroid-treated and resolved AD lesions. Methods: Patients (n = 67) with resolved AD lesions were randomized to 3-week double-blind treatment with either pimecrolimus cream 1% or vehicle cream...

...D. Spoerl; K. Scherer; A.J. Bircher We report a case of severe contact urticaria with systemic involvement resembling an anaphylactic reaction, following the application of a topical corticosteroid. This was caused by hexylene glycol, an excipient in the formulation. Glycols are widely used...

...E. Grunnet; A. Nyfors; Brogaard Hansen Ejaculates were studied from ten men with severe psoriasis treated with topical corticosteroids and from ten similar patients who had received methotrexate therapy from 1 to 9 years. It was not possible to demonstrate any unfavorable effect on the semen...

...Kays Kaidbey The sequential application of full-strength dimethylsulfoxide (DMSO) and potent topical corticosteroid preparations was very effective in resistant plaque-type psoriasis. Complete clearing may be achieved in 3–4 weeks. Lower strengths of DMSO were less beneficial. Irritation from...

... to Synalar® ointment and cream (fluocinolone acetonide 0.025%), established topical corticosteroid preparations. Statistical analysis showed no significant differences between similar formulations of diflucortolone valerate. Significant differences were noted between diflucortolone valerate and fluocinolone...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Blanching activity Topical corticosteroids Betamethasone 17-valerate...

... corticosteroids Blanching effect Betamethasone dipropionate Hydrocortisone 17-butyrate Triamcinolone acetonide Dermatologica 161: 84-88 (1980) Suppression of Ultraviolet Erythema by Topical Corticosteroids H. Sukanto, J. P. Nater and E. Bleumink Department of Dermatology, Airlangga University, Surabaya...

...% domoprednate is comparable to other topical corticosteroids with respect to atrophogeneity and formation of telangiectasia, but the 0.03% concentration seems to result in fewer side effects. Topical corticosteroids Domoprednate Placebo Skin atrophy Telangiectasia Randomized trial © 1985 S. Karger...

...B. Vandercam; J.M. Lachapelle; P. Janssens; D. Tennstedt; M. Lambert We describe an HIV-negative homosexual man who developed Kaposi’s sarcoma (KS). He had CD4 lymphocytopenia during azathioprine and topical corticosteroid therapy for atopic dermatitits (AD). KS was observed after only 2 months...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Pimecrolimus Tacrolimus Topical corticosteroids Atopic dermatitis Lymphoma Drug safety Pimecrolimus (Elidel®...

... scheme. Atopic dermatitis Atopic eczema Long-term control Randomized controlled trial Topical calcineurin inhibitors Topical corticosteroids Treatment algorithm Atopic eczema (AE, synonymous with atopic dermatitis) is a multifactorial, itchy, inflammatory skin disease that affects up...

...R. Foelster-Holst; F. Nagel; P. Zoellner; D. Spaeth Background: The wet-wrap treatment has been reported to be beneficial in acute episodes of atopic dermatitis (AD) skin lesions. Objective: The efficacy of topical corticosteroid prednicarbat with and without additional wet-wrap dressing...

...Thomas Hultsch; Alexander Kapp; Jonathan Spergel Atopic dermatitis (AD) is a chronic or chronically relapsing inflammatory skin condition that primarily affects children. Topical corticosteroids have been the mainstay of treatment since the late 1950s. While providing excellent short-term efficacy...

... as required. A moderately potent topical corticosteroid (prednicarbate 0.25% cream) was allowed in both groups to treat flares. Results: Corticosteroids were required on fewer days in the pimecrolimus group, compared with the vehicle group (9.7 vs. 37.8%, p < 0.001). Furthermore, 59.7% of pimecrolimus...